Cargando…

The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment

OBJECTIVE: Effects of transient combination antiretroviral treatment (cART) initiated during early HIV infection (EHI) remain unclear. We investigate whether this intervention affects viral suppression and CD4(+) cell count increase following its reinitiation in chronic infection (CHI). DESIGN: Long...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pantazis, Nikos, Touloumi, Giota, Meyer, Laurence, Olson, Ashley, Costagliola, Dominique, Kelleher, Anthony D., Lutsar, Irja, Chaix, Marie-Laure, Fisher, Martin, Moreno, Santiago, Porter, Kholoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794189/ https://www.ncbi.nlm.nih.gov/pubmed/26636925 http://dx.doi.org/10.1097/QAD.0000000000000991

Ejemplares similares

Virologic and Immunologic Response to cART by HIV-1 Subtype in the CASCADE Collaboration
por: Touloumi, Giota, et al.
Publicado: (2013)

The Effect of HIV Treatment Interruption on Subsequent Immunological Response
por: Thomadakis, Christos, et al.
Publicado: (2023)

HIV continuum of care: expanding scope beyond a cross-sectional view to include time analysis: a systematic review
por: Vourli, Georgia, et al.
Publicado: (2021)

Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4(+) T-cell recovery once HIV-1 suppression is achieved?
por: Jarrin, Inma, et al.
Publicado: (2015)

Changes in Body Mass Index after Initiation of Antiretroviral Treatment: Differences by Class of Core Drug
por: Pantazis, Nikos, et al.
Publicado: (2022)

Differences in HIV Natural History among African and Non-African Seroconverters in Europe and Seroconverters in Sub-Saharan Africa
por: Pantazis, Nikos, et al.
Publicado: (2012)

Clinical Progression Rates by CD4 Cell Category Before and After the Initiation of Combination Antiretroviral Therapy (cART)
por: Guiguet, Marguerite, et al.
Publicado: (2008)

HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors
por: Paraskevis, Dimitrios, et al.
Publicado: (2019)

Towards standardized definitions for monitoring the continuum of HIV care in Europe
por: Gourlay, Annabelle J., et al.
Publicado: (2017)

CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada
por: Ruiz-Burga, Elisa, et al.
Publicado: (2023)

Antiretroviral drug resistance and viral tropism in HIV-1 CRF06_cpx infected patients failing antiretroviral (ARV) therapy
por: Pauskar, Merit, et al.
Publicado: (2014)

Kaposi Sarcoma Incidence and Survival Among HIV-Infected Homosexual Men After HIV Seroconversion
por: Lodi, Sara, et al.
Publicado: (2010)

Immunological response to highly active antiretroviral therapy following treatment for prevention of mother to child transmission of HIV-1: a study in Côte d'Ivoire
por: Ekouevi, Didier K, et al.
Publicado: (2010)

Substantial Heterogeneity in Progress Toward Reaching the 90-90-90 HIV Target in the WHO European Region
por: Porter, Kholoud, et al.
Publicado: (2018)

Immunological predictors of CD4(+ )T cell decline in antiretroviral treatment interruptions
por: Seoane, Elena, et al.
Publicado: (2008)

Are European HIV cohort data within EuroCoord representative of the diagnosed HIV population?
por: Vourli, Georgia, et al.
Publicado: (2019)

An Evaluation of HIV Elite Controller Definitions within a Large Seroconverter Cohort Collaboration
por: Olson, Ashley D., et al.
Publicado: (2014)

New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon
por: Ndawinz, Jacques DA, et al.
Publicado: (2015)

Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals
por: Cain, Lauren E., et al.
Publicado: (2016)

Antibiotic prescription preferences in paediatric outpatient setting in Estonia and Sweden
por: Lass, Jana, et al.
Publicado: (2013)

People living with HIV in Estonia: engagement in HIV care in 2013
por: Laisaar, Kaja-Triin, et al.
Publicado: (2016)

Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda
por: Ahoua, Laurence, et al.
Publicado: (2009)

Sensitive Assessment of the Virologic Outcomes of Stopping and Restarting Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy
por: Geretti, Anna Maria, et al.
Publicado: (2013)

The HIV patient profile in 2013 and 2003: Results from the Greek AMACS cohort
por: Pantazis, Nikos, et al.
Publicado: (2018)

Could the 2010 HIV outbreak in Athens, Greece have been prevented? A mathematical modeling study
por: Gountas, Ilias, et al.
Publicado: (2021)

Framework conditions facilitating paediatric clinical research
por: Knellwolf, Anne-Laure, et al.
Publicado: (2011)

Low pre-ART CD4 count is associated with increased risk of clinical progression or death even after reaching 500 CD4 cells/μL on ART
por: Pantazis, Nikos, et al.
Publicado: (2023)

Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
por: Padari, Helgi, et al.
Publicado: (2016)

A randomized trial comparing concise and standard consent forms in the START trial
por: Grady, Christine, et al.
Publicado: (2017)

Relationship between Regulatory T Cells and Immune Activation in Human Immunodeficiency Virus-Infected Patients Interrupting Antiretroviral Therapy
por: Weiss, Laurence, et al.
Publicado: (2010)

Meropenem vs standard of care for treatment of late onset sepsis in children of less than 90 days of age: study protocol for a randomised controlled trial
por: Lutsar, Irja, et al.
Publicado: (2011)

Limiting Cumulative HIV Viremia Copy-Years by Early Treatment Reduces Risk of AIDS and Death
por: Olson, Ashley D., et al.
Publicado: (2016)

Laboratory markers to determine clinical significance of coagulase-negative staphylococci in blood cultures
por: Mitt, Piret, et al.
Publicado: (2007)

Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care?
por: Baldé, Aliou, et al.
Publicado: (2020)

An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial
por: Hill, Louise F., et al.
Publicado: (2020)

Comparison of two alternative study designs in assessment of medicines utilisation in neonates
por: Nellis, Georgi, et al.
Publicado: (2014)

Hospitalised neonates in Estonia commonly receive potentially harmful excipients
por: Lass, Jana, et al.
Publicado: (2012)

Peripheral blood RNA gene expression profiling in patients with bacterial meningitis
por: Lill, Margit, et al.
Publicado: (2013)

Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals
por: Clarridge, Katherine E., et al.
Publicado: (2018)

Adherence to contemporary antiretroviral treatment regimens and impact on immunological and virologic outcomes in a US healthcare system
por: T. Tchakoute, Christophe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rh6cg0f00lr56i18vkq74g21eu